Nezam H. Afdhal, Chief Medical Officer at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 2,600 shares at $11.33 ($29K) on 2016-08-12, disclosed to the SEC on 2016-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SBPH | BUY | 2016-08-16 | $22K | — | Filing → |
| SBPH | BUY | 2016-08-16 | $57K | — | Filing → |